메뉴 건너뛰기




Volumn 64, Issue 11, 2005, Pages 1968-1970

Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validity

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NERVE POTENTIAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

EID: 20444402586     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000163988.28892.79     Document Type: Article
Times cited : (115)

References (7)
  • 1
    • 0034000824 scopus 로고    scopus 로고
    • Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis
    • Sharshar T, Chevret S, Mazighi M, et al. Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis. J Neurol 2000;247:286-289.
    • (2000) J Neurol , vol.247 , pp. 286-289
    • Sharshar, T.1    Chevret, S.2    Mazighi, M.3
  • 2
    • 0034641222 scopus 로고    scopus 로고
    • Myasthenia gravis - Recommendations for clinical research standards
    • Jaretzki A, Barohn R, Ernstoff H, et al. Myasthenia gravis- recommendations for clinical research standards. Neurology 2000;55:16-23.
    • (2000) Neurology , vol.55 , pp. 16-23
    • Jaretzki, A.1    Barohn, R.2    Ernstoff, H.3
  • 3
    • 0036789453 scopus 로고    scopus 로고
    • Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis
    • Wolfe G, Barohn R, Foster B, et al. Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve 2002;26:549-552.
    • (2002) Muscle Nerve , vol.26 , pp. 549-552
    • Wolfe, G.1    Barohn, R.2    Foster, B.3
  • 4
    • 0035830461 scopus 로고    scopus 로고
    • Mycophenolate mofetil for myasthenia gravis: An open label pilot study
    • Ciafaloni E, Massey J, Tucker-Lipscomb B, Sanders D. Mycophenolate mofetil for myasthenia gravis: an open label pilot study. Neurology 2001;56:97-99.
    • (2001) Neurology , vol.56 , pp. 97-99
    • Ciafaloni, E.1    Massey, J.2    Tucker-Lipscomb, B.3    Sanders, D.4
  • 5
    • 0344874547 scopus 로고    scopus 로고
    • Mycophenolate mofetil for myasthenia gravis: An analysis of efficacy, safety and tolerability
    • Meriggioli M, Ciafaloni E, Al-Hayk K, et al. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety and tolerability. Neurology 2003;61:1438-1440.
    • (2003) Neurology , vol.61 , pp. 1438-1440
    • Meriggioli, M.1    Ciafaloni, E.2    Al-Hayk, K.3
  • 6
    • 0023154612 scopus 로고
    • Measuring change over time: Assessing the usefulness of evaluative instruments
    • Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171-178.
    • (1987) J Chron Dis , vol.40 , pp. 171-178
    • Guyatt, G.1    Walter, S.2    Norman, G.3
  • 7
    • 2442696378 scopus 로고    scopus 로고
    • Improving the responsiveness of rating scales
    • Cudkowicz M, Schoenfeld D, Williams L. Improving the responsiveness of rating scales. Neurology 2004;62:1666-1667.
    • (2004) Neurology , vol.62 , pp. 1666-1667
    • Cudkowicz, M.1    Schoenfeld, D.2    Williams, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.